Contact DMCA Privacy

Robuta

https://pubmed.ncbi.nlm.nih.gov/38680706/
Teneligliptin mitigates diabetic cardiomyopathy by inhibiting activation of the NLRP3 inflammasome
Overall, teneligliptin mitigated DCM by mitigating activation of the NLRP3 inflammasome.
diabetic cardiomyopathyteneligliptinmitigatesinhibitingactivation